TY - JOUR
T1 - Care of the adult hodgkin lymphoma survivor
AU - Thompson, Carrie A.
AU - Mauck, Karen
AU - Havyer, Rachel
AU - Bhagra, Anjali
AU - Kalsi, Henna
AU - Hayes, Sharonne N.
PY - 2011/12
Y1 - 2011/12
N2 - Of those individuals diagnosed with Hodgkin lymphoma, 85% will survive and may be affected by residual effects of their cancer and its therapy (chemotherapy, radiation therapy, stem cell transplantation). Hodgkin lymphoma survivors are at risk of developing secondary malignancies, cardiovascular disease, pulmonary disease, thyroid disease, infertility, premature menopause, chronic fatigue, and psychosocial issues. These conditions usually have a long latency and therefore present years or decades after Hodgkin lymphoma treatment, when the patient's care is being managed by a primary care provider. This review summarizes these unique potential medical and psychologic sequelae of Hodgkin lymphoma, and provides screening and management recommendations.
AB - Of those individuals diagnosed with Hodgkin lymphoma, 85% will survive and may be affected by residual effects of their cancer and its therapy (chemotherapy, radiation therapy, stem cell transplantation). Hodgkin lymphoma survivors are at risk of developing secondary malignancies, cardiovascular disease, pulmonary disease, thyroid disease, infertility, premature menopause, chronic fatigue, and psychosocial issues. These conditions usually have a long latency and therefore present years or decades after Hodgkin lymphoma treatment, when the patient's care is being managed by a primary care provider. This review summarizes these unique potential medical and psychologic sequelae of Hodgkin lymphoma, and provides screening and management recommendations.
KW - Hodgkin lymphoma
KW - Primary care physicians
KW - Survivors
UR - http://www.scopus.com/inward/record.url?scp=81855220397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81855220397&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2011.05.020
DO - 10.1016/j.amjmed.2011.05.020
M3 - Review article
C2 - 22114824
AN - SCOPUS:81855220397
SN - 0002-9343
VL - 124
SP - 1106
EP - 1112
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 12
ER -